Huang T - Search Results

1

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.

Rong D, Wang Y, Liu L, Cao H, Huang T, Liu H, Hao X, Sun G, Sun G, Zheng Z, Kang J, Xia Y, Chen Z, Tang W, Wang X. Rong D, et al. Among authors: huang t. J Immunother Cancer. 2023 Feb;11(2):e005126. doi: 10.1136/jitc-2022-005126. J Immunother Cancer. 2023. PMID: 36787938 Free PMC article.

2

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.

Kong X, Zheng Z, Song G, Zhang Z, Liu H, Kang J, Sun G, Sun G, Huang T, Li X, Rong D, Wang K, Tang W, Xia Y. Kong X, et al. Among authors: huang t. Front Immunol. 2022 Jun 22;13:876048. doi: 10.3389/fimmu.2022.876048. eCollection 2022. Front Immunol. 2022. PMID: 35812439 Free PMC article.

3

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.

Cao H, Huang T, Dai M, Kong X, Liu H, Zheng Z, Sun G, Sun G, Rong D, Jin Z, Tang W, Xia Y. Cao H, et al. Among authors: huang t. Int J Biol Sci. 2022 Aug 21;18(14):5369-5390. doi: 10.7150/ijbs.73949. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147461 Free PMC article. Review.

4

Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma.

Kang J, Zheng Z, Li X, Huang T, Rong D, Liu X, Qin M, Wang Y, Kong X, Song J, Lv C, Pan X. Kang J, et al. Among authors: huang t. Cancer Cell Int. 2022 Oct 12;22(1):312. doi: 10.1186/s12935-022-02735-3. Cancer Cell Int. 2022. PMID: 36224624 Free PMC article.

5

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study.

Zhao J, Guo Y, Ding W, Han G, Jiang C, Yang C, Hu Y, Zhang L, Wu C, Ni M, Kong X, Huang T, Zhang C, Xia Y. Zhao J, et al. Among authors: huang t. Front Oncol. 2022 Oct 6;12:965711. doi: 10.3389/fonc.2022.965711. eCollection 2022. Front Oncol. 2022. PMID: 36276134 Free PMC article.

6

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.

Sun G, Liu H, Zhao J, Zhang J, Huang T, Sun G, Zhao S, Zhang Z, Cao H, Rong D, Kong X, Ji Q, Liu L, Wang X, Tang W, Xia Y. Sun G, et al. Among authors: huang t. J Immunother Cancer. 2022 Dec;10(12):e005655. doi: 10.1136/jitc-2022-005655. J Immunother Cancer. 2022. PMID: 36600662 Free PMC article.

7

CHSY1 promotes CD8⁺ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening.

Sun G, Zhao S, Fan Z, Wang Y, Liu H, Cao H, Sun G, Huang T, Cai H, Pan H, Rong D, Gao Y, Tang W. Sun G, et al. Among authors: huang t. J Exp Clin Cancer Res. 2023 Sep 25;42(1):248. doi: 10.1186/s13046-023-02803-0. J Exp Clin Cancer Res. 2023. PMID: 37749638 Free PMC article.

8

Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.

Tang W, Sun G, Ji GW, Feng T, Zhang Q, Cao H, Wu W, Zhang X, Liu C, Liu H, Huang T, Liu L, Xia Y, Wang X. Tang W, et al. Among authors: huang t. J Immunother Cancer. 2023 Nov 24;11(11):e007030. doi: 10.1136/jitc-2023-007030. J Immunother Cancer. 2023. PMID: 38007237 Free PMC article.

9

Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study.

Zhao J, Guo Y, Feng T, Rong D, Kong X, Huang T, Lopez-Lopez V, Yarmohammadi H, Sakamoto Y, Zhu D, Yao A, Xia Y. Zhao J, et al. Among authors: huang t. J Gastrointest Oncol. 2023 Dec 31;14(6):2549-2558. doi: 10.21037/jgo-23-590. Epub 2023 Dec 27. J Gastrointest Oncol. 2023. PMID: 38196523 Free PMC article.

10

New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma.

Liu H, Wang C, Wang R, Cao H, Cao Y, Huang T, Lu Z, Xiao H, Hu M, Wang H, Zhao J. Liu H, et al. Among authors: huang t. Chin J Cancer Res. 2024 Apr 30;36(2):167-194. doi: 10.21147/j.issn.1000-9604.2024.02.06. Chin J Cancer Res. 2024. PMID: 38751435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,407 results

Search Page

Filters